{"retracted":false,"update":{"timestamp":1417392000000,"doi":"10.1016/j.ygyno.2014.08.011","type":"err"},"doi":"10.1016/j.ygyno.2014.02.036","journal":"Gynecologic Oncology","publisher":"Elsevier BV","title":"Corrigendum to: A phase II evaluation of Pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group Study [Gynecol Oncol 133 (2014) 537â€“541]"}
